Deals

AlpInvest leads €600m GP-led on specialty pharma asset

Swiss GP Gyrus Capital originally invested in Essential Pharma in 2019 as part of a family/founder succession plan process.

NYC pension systems disclose details of multi-billion sale

The New York City retirement systems confirmed that four of the five NYC pension funds are involved in the large LP-led secondaries transaction.

Ares emerges as buyer on AXA’s LP-led deal

The process involves moving stakes into a new managed fund, Secondaries Investor has learned.

NYCERS explores $1bn-plus LP-led secondaries process

NYCRS, which oversees five pensions including NYCERS, has a secondaries programme in place with long-term targets ranging from 10-20% of its total PE portfolio.

Partners Group to build ‘local clusters of scale’ with Bluesea Hotels M&A

The private markets firm backed a GP-led process involving Spain’s Bluesea, a hospitality platform.

AlpInvest and Coller step up as lead buyers on Advent’s single-asset CV

Advent is seeking to move business management software, payments and commerce-related technologies provider Xplor into a separate vehicle.

Mastercard Foundation buys $764m of illiquid assets from Kodak pension

The Campbell Lutyens-advised sale comes as the Eastman Kodak Company mulls a potential termination of its pension plan.

Secondaries Investor CV Deal Log Q1-Q3 2024 – updated

Download our latest list of the continuation funds that were known or disclosed during the first nine months of this year.

Warburg Pincus explores building internal team to invest in continuation fund deals

Warburg’s move comes as several other large GPs have built out internal secondary capabilities, including TPG and Leonard Green & Partners.

CPP Investments was sole buyer of PSG’s multi-fund tender

The Canadian pension giant was able to secure priority allocation and fill its intended exposure as the lead in the process, Secondaries Investor understands.